tradingkey.logo
tradingkey.logo
Search

Volition Announces MARS Consortium Clinical Study Suggests Nu.Q H3.1 Concentrations Are Closely Associated With Sepsis And Organ Failure

ReutersJun 12, 2025 12:51 PM
facebooktwitterlinkedin

- VolitionRX Ltd VNRX.A:

  • VOLITION ANNOUNCES MARS CONSORTIUM CLINICAL STUDY SUGGESTS NU.Q® H3.1. CONCENTRATIONS ARE CLOSELY ASSOCIATED WITH SEPSIS AND ORGAN FAILURE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI